Metabolomics in Drug Discovery

Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs.

  • Drug metabolism during drug design and development
  • Metabolites in identification of drug targets
  • Metabonomics in preclinical pharmaceutical discovery and development
  • Toxicology and drug metabolism
  • QSAR and ligand-receptor models
  • Applications in Drug Development

Related Conference of Metabolomics in Drug Discovery

June 13-14, 2024

30th Asia Pacific Biotechnology Congress

Dubai, UAE
July 11-12, 2024

6th International Conference on Biochemistry

Paris, France
September 25-26, 2024

20th World Congress on Structural Biology

Paris, France
October 03-04, 2024

15th International Conference on Biofuels and Bioenergy

Singapore City, Singapore
December 12-13, 2024

15th World Congress on Cell & Tissue Science

Rome, Italy

Metabolomics in Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in